Skip to main content
OpenTrials
Completed

NCT Number: NCT07424937

Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age

The French National Authority for Health (Haute Autorité de Santé, HAS) recommends regular gynecological follow-up, specifying that it is considered regular when it is annual. The objectives of this gynecological follow-up are multiple: to support women in the choice and management of contraception as well as in their sexuality; to screen for cervical cancer and breast cancer; to diagnose and to take care of sexually transmitted infections (STIs); and to diagnose and treat gynecological conditions such as adenomyosis, endometriosis, polycystic ovary syndrome, etc. Regarding cervical cancer screening, the HAS recommends performing a Pap smear (cervical cytology) starting at the age of 25 and up to the age of 65.

Several studies, such as those by Henry et al. in 2020 and Owokuhaisa et al. in 2024, have identified major barriers to access to gynecological care for women. These barriers include very long waiting times, lack of privacy, lack of understanding or access to appropriate information, discomfort or fear during consultations, shortage of physicians, past negative experiences, etc. These factors may contribute to women postponing or even forgoing their gynecological consultations. A study by Landy et al. in 2021 also showed that women diagnosed with advanced-stage cervical cancer had not undergone regular screening or gynecological follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Ufr Medecine Urca

Reims, 51100, France

About this study

Objectives Primary: To describe the prevalence of regular gynecological follow-up among women of childbearing age.

Secondary:

  • To describe women's knowledge regarding gynecological follow-up
  • To investigate the factors associated with women's regular gynecological follow-up, particularly the desire for pregnancy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women aged 18 years and over
  • Are not menopausal
  • Have or do not have a desire for pregnancy
  • Have children or do not have children
  • Have a sexual partner or not
  • Reside in metropolitan France or in the French overseas department.
  • Agreeing to participate in the study

Exclusion criteria

  • Being pregnant
  • Being legally protected (guardianship, curatorship, judicial protection)

Treatment and study plan

Data Collection

Other

data collection

Primary outcomes

  1. The prevalence of regular gynecological follow-up

    Time frame: Day 0

    Regular gynecological follow-up (according to HAS recommendations: once per year) and, if irregular, the frequency of follow-up: once every two to three years, occasionally, more than three years ago, or never consulted

Sponsors and collaborators

Lead sponsor

Université de Reims Champagne-Ardenne

Other

Registry information

Acronym: Suivi-gynéco

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 20, 2026
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.